Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
The transaction transforms Nuvectis into a late-stage clinical development company by expanding its pipeline into complement-mediated diseases ...
Lexeo Therapeutics is a clinical-stage gene therapy company focused on inherited cardiac diseases. Their main value driver is LX2006 for Friedreich's ataxia (FA) cardiomyopathy. LX2006 currently has a ...
APPLETON, WI - June 30, 2026 - PRESSADVANTAGE - As the summer season advances and homeowners increasingly utilize their ...
Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.
IIT Kanpur researchers solve mystery of atypical drug target receptor ...
The Princess of Wales completed the Three Peaks challenge to raise money for the hospital where she was treated ...
Systemic lupus erythematosus (SLE) is a chronic, complex autoimmune disease that can affect multiple organ systems, with ...
Intellectual Property / Electric Propulsion Technology. New U.S. patent filing advances E-Motion™ electric outboard ...
Everyday Health on MSN
Coffee may lower the risk of serious liver disease
A new study of more than 350,000 people suggests coffee, regular and decaf, may protect against serious liver ailments. Learn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results